Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Tough to argue STADA's place in the European Pharma game.

<< Previous

Bullboard Posts

Next >>

Comment by subaru1ion Mar 26, 2024 8:55pm

64 Views

Post# 35954393

RE:RE:RE:Tough to argue STADA's place in the European Pharma game.

Contract development and manufacturing organization (CDMO) Norbitec biotech, a joint venture between generics firm Stada and biologics firm Nordmark, will supply Pfizer with Retacrit from its site in Uetersen, about 20km northwest of Hamburg, Germany for the US market, following accreditation from the US Food and Drug Administration (FDA).

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for June 17, 2024